2013 | Aarkstore.in || Premature Labor (Tocolysis) – Pipeline Review, H2 2012 by winaarkstore


									You can also request for sample page of above
mention reports on Customersupport@aarkstore.com
Price :
$ 2000 - PDF | $ 4000 - Site Licence | $ 6000 - Corporate Licence

Pages : 61

Global Markets Direct’s, Premature Labor (Tocolysis) - Pipeline Review, H2
2012, provides an overview of the indication’s therapeutic pipeline. This report
provides information on the therapeutic development for Premature Labor
(Tocolysis), complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Premature Labor (Tocolysis). Premature Labor (Tocolysis) -
Pipeline Review, Half Year is built using data and information sourced from
Global Markets Direct’s proprietary databases, Company/University websites,
SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together
by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

- A snapshot of the global therapeutic scenario for Premature Labor (Tocolysis).
 - A review of the Premature Labor (Tocolysis) products under development by
companies and universities/research institutes based on information derived
from company and industry-specific sources.
 - Coverage of products based on various stages of development ranging from
discovery till registration stages.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under
development for Premature Labor (Tocolysis).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
- Devise corrective measures for pipeline projects by understanding Premature
Labor (Tocolysis) pipeline depth and focus of Indication therapeutics.
Table Of Contents

List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Premature Labor (Tocolysis) Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Premature Labor (Tocolysis) 8
Premature Labor (Tocolysis) Therapeutics under Development by Companies
Premature Labor (Tocolysis) Therapeutics under Investigation by
Universities/Institutes 11
Late Stage Products 12
Comparative Analysis 12
Mid Clinical Stage Products 13
Comparative Analysis 13
Early Clinical Stage Products 14
Comparative Analysis 14
Pre-Clinical Stage Products 15
Comparative Analysis 15……………..
More Related Reports:


Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) – Pipeline
Review, H2 2012

Basal Cell Carcinoma (Basal Cell Epithelioma) – Pipeline Review, H2

Diabetic Peripheral Neuropathy – Pipeline Review, H2 2012

Opioid-Induced Constipation (OIC) – Pipeline Review, H2 2012

Premature Labor (Tocolysis) – Pipeline Review, H2 2012
For More details about above & other Reports
plz contact :


Contact: Marketing team
Email: enquiry@aarkstore.com
URL: http://www.aarkstore.com

To top